HomeAI · summaries
Storia in 2 fonti
The biotech recovery gathers speed in Q2
Biopharma dealmaking rebounds in Q2 2026: M&A nears $80B and licensing/R&D alliances hit a 5-year record $83B, per DealForma.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
afr.com
Biotech deals surge to record as fear of missing out grips big pharma
The prospect of patents expiring on lucrative drugs is prompting drugmakers to hunt for the next blockbuster medicines.
- ·
endpoints.news
The biotech recovery gathers speed in Q2
Biopharma dealmaking rebounds in Q2 2026: M&A nears $80B and licensing/R&D alliances hit a 5-year record $83B, per DealForma.